Share this Article
Yang J, Ji S, Zhang Y, Wang J
Correspondence: Dr Jiangbin Wang, sciencel122@126.com
ABSTRACT
INTRODUCTION Helicobacter (H.) hepaticus infection causes chronic active hepatitis and induces hepatocellular tumours in A/JCr mice, but evidence of this in humans is scarce. This study aimed to demonstrate the correlation between H. hepaticus and human primary hepatocellular carcinoma (HCC).
METHODS The sera of 50 patients with primary HCC were tested for the presence of anti-H. pylori and anti-H. hepaticus immunoglobulin G (IgG) antibodies. The liver tissues of patients who tested positive for serum antibody were analysed for H. hepaticus-specific 16S rRNA, H. hepaticus cdtB, H. pylori cagA, H. pylori vacA and H. pylori ureC genes using polymerase chain reaction.
RESULTS After the anti-H. pylori antibodies in the serum samples were absorbed by H. pylori antigen, the anti-H. hepaticus IgG serum antibody detection rate was 50.0% in patients with primary HCC. This was significantly higher (p < 0.001) than the detection rate in the benign liver tumour (7.7%) and normal liver tissue (6.3%) groups. Of the 25 primary HCC samples that tested positive for anti-H. hepaticus IgG serum antibody, the H. hepaticus-specific 16S rRNA gene was detected in nine (36.0%) samples. Sequencing showed that the polymerase chain reaction-amplified product exhibited 95.5%–100% homology to the H. hepaticus-specific 16S rRNA gene. Among these nine primary HCC tissue samples, the H. hepaticus cdtB gene was detected in four (44.4%) samples, while no such expression was observed in the benign liver tumour or normal liver tissue groups.
CONCLUSION The present study identified the presence of H. hepaticus infection in patients with primary HCC using serological and molecular biological detection, suggesting that H. hepaticus infection may be involved in the progression of HCC.
Keywords: Helicobacter hepaticus, Helicobacter pylori, primary hepatocellular carcinoma
Singapore Med J 2013; 54(8): 451-457; http://dx.doi.org/10.11622/smedj.2013153
REFERENCES
| 1. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36 (5 Suppl 1):S74-83. http://dx.doi.org/10.1053/jhep.2002.36807 | ||||
| 2. Nissen NN, Martin P. Hepatocellular carcinoma: the high-risk patient. J Clin Gastroenterol 2002; 35 (5 Suppl 1):S79-85. http://dx.doi.org/10.1097/00004836-200211002-00003 | ||||
| 3. Smela ME, Currier SS, Bailey EA, Essigmann JM. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 2001; 22:535-45. http://dx.doi.org/10.1093/carcin/22.4.535 | ||||
| 4. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000; 248:171-83. http://dx.doi.org/10.1046/j.1365-2796.2000.00742.x | ||||
| 5. Silini E, Bottelli R, Asti M, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 1996; 111:199-205. http://dx.doi.org/10.1053/gast.1996.v111.pm8698200 | ||||
| 6. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000; 32:91-6. http://dx.doi.org/10.1053/jhep.2000.8169 | ||||
| 7. Barrett S, Goh J, Coughlan B, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001; 49:423-30. http://dx.doi.org/10.1136/gut.49.3.423 | ||||
| 8. Vandenplas Y. Helicobacter pylori infection. World J Gastroenterol 2000; 6:20-31. | ||||
| 9. Sakai T, Ogura Y, Narita J, et al. Simultaneous early adenocarcinoma and mucosaassociated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection. Gastric Cancer 2003; 6:191-6. http://dx.doi.org/10.1007/s10120-003-0241-8 | ||||
| 10. Vergara M, Calvet X, Roqué M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 2002; 14:717-22. http://dx.doi.org/10.1097/00042737-200207000-00002 | ||||
| 11. Ward JM, Fox JG, Anver MR, et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994; 86:1222-7. http://dx.doi.org/10.1093/jnci/86.16.1222 | ||||
| 12. Nilsson HO, J Taneera, M Castedal, et al. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38:1072-6. | ||||
| 13. Vorobjova T, I Nilsson, S Terjajev, et al. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection. Dig Liver Dis 2006; 38:171-6. http://dx.doi.org/10.1016/j.dld.2005.12.008 | ||||
| 14. Nilsson I, Kornilovs'ka I, Lindgren S, Ljungh A, Wadström T. Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease. J Med Microbiol 2003; 52:949-53. http://dx.doi.org/10.1099/jmm.0.05344-0 | ||||
| 15. Huang Y, Fan XG, Wang ZM, et al. Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004; 57:1273-7. http://dx.doi.org/10.1136/jcp.2004.018556 | ||||
| 16. Shimoyama T, Takahashi R, Abe D, et al. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 2010; 25 Suppl 1:S86-9. http://dx.doi.org/10.1111/j.1440-1746.2010.06224.x | ||||
| 17. Ananieva O, Nilsson I, Vorobjova T, Uibo R, Wadström T. Immune responses to biletolerant Helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors. Clin Diagn Lab Immunol 2002; 9:1160-4. | ||||
| 18. Nilsson I, Lindgren S, Eriksson S, Wadström T. Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease. Gut 2000; 46:410-4. http://dx.doi.org/10.1136/gut.46.3.410 | ||||
| 19. Ihrig M, Schrenzel MD, Fox JG. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 1999; 155:571-82. http://dx.doi.org/10.1016/S0002-9440(10)65152-8 | ||||
| 20. Rogers AB, SR Boutin, MT Whary, et al. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 2004; 32:668-77. http://dx.doi.org/10.1080/01926230490524247 | ||||
| 21. Avenaud P, Marais A, Monteiro L, et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000; 89:1431-9. http://dx.doi.org/10.1002/1097-0142(20001001)89:7<1431::AID-CNCR4>3.0.CO;2-5 | ||||
| 22. Ponzetto A, Pellicano R, Leone N, et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 2000; 54:275-7. http://dx.doi.org/10.1054/mehy.1999.0987 | ||||
| 23. Nilsson HO, Mulchandani R, Tranberg KG, Stenram U, Wadström T. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 2001; 120:323-4. http://dx.doi.org/10.1053/gast.2001.21382 | ||||
| 24. Fan XG, Peng XN, Huang Y, et al. Helicobacter species ribosomal DNA recovered from the liver tissue of chinese patients with primary hepatocellular carcinoma. Clin Infect Dis 2002; 35:1555-7. http://dx.doi.org/10.1086/344770 | ||||
| 25. Coppola N, De Stefano G, Marrocco C, et al. Absence of Helicobacter spp. in the liver of patients with primary or metastatic liver cancer. Hepatology 2002; 36:1300-1. http://dx.doi.org/10.1053/jhep.2002.36367 | ||||
| 26. Verhoef C, Pot RG, de Man RA, et al. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2003; 15:1171-4. http://dx.doi.org/10.1097/00042737-200311000-00004 | ||||
| 27. Pellicano R, Mazzaferro V, Grigioni WF, et al. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol 2004; 10:598-601. | ||||
| 28. Ito K, M Nakamura, G Toda, et al. Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 2004; 13:221-7. | ||||
| 29. Rocha M, Avenaud P, Ménard A, Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005; 54:396-401. http://dx.doi.org/10.1136/gut.2004.042168 | ||||
| 30. Fox JG, Li X, Yan L, et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis. Infect Immun 1996; 64:1548-58. | ||||
| 31. Murakami K, Takahashi R, Ono M, et al. Serodiagnosis of Helicobacter hepaticus infection in patients with liver and gastrointestinal diseases: western blot analysis and ELISA using a highly specific monoclonal antibody for H. hepaticus antigen. J Gastroenterol 2011; 46:1120-6. http://dx.doi.org/10.1007/s00535-011-0414-x | ||||